Travoprost Ophthalmic Solution NDC 68083-601

NDC codes

FDA NDC Directory

Product NDC (as listed)68083-601Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68083-0601Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68083-601-01	68083060101	1 BOTTLE in 1 CARTON (68083-601-01) / 2.5 mL in 1 BOTTLEMarketed from Jul 12, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Travoprost Ophthalmic Solution
Generic name (nonproprietary): travoprost ophthalmic solution
Active ingredients: Travoprost — .04 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Gland Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218159
Marketing start: Jul 12, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Prostaglandins (Chemical structure)
Identifiers: Product ID 68083-601_7c35e414-614e-4d70-96ff-3adae7238166SPL ID 7c35e414-614e-4d70-96ff-3adae7238166SPL set ID 71c9ea95-f577-411a-8e22-819e44d9680eRxCUI 284008UNII WJ68R08KX9
Pharmacologic class: Prostaglandin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468083060101 followed by a unit qualifier and the quantity

Package 68083-0601-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 2, 2025.

Indications (excerpt from the label)

Travoprost ophthalmic solution (ionic buffered solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Travoprost ophthalmic solution (ionic buffered solution) is a prostaglandin analog indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218159

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218159
Product	Strength	Form · route	Labeler	Product NDC
Travoprost Ophthalmic Solutontravoprost	Travoprost .04 mg/mL	Solution/ dropsOphthalmic	Sagent Pharmaceuticals	25021-002
Travoprost Ophthalmic Solution	Travoprost .04 mg/mL	Solution/ dropsOphthalmic	GLENMARK PHARMACEUTICALS INC	68462-943
Travoprost Ophthalmic Solution	Travoprost .04 mg/mL	Solution/ dropsOphthalmic	Gland Pharma Limited	68083-602